What's in Steba Biotech S.A.'s pipeline?

Steba Biotech S.A. has 4 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Steba Biotech S.A.'s portfolio?

Top competitors by shared drug class: Biofrontera Bioscience GmbH, DUSA Pharmaceuticals, Inc., Galderma R&D, Joint Authority for Päijät-Häme Social and Health Care, National Cancer Center, Korea.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/steba-biotech-s-a.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Steba Biotech S.A. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Steba Biotech S.A. pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
TOOKAD VTP	TOOKAD VTP	marketed	Photodynamic therapy agent	Vascular endothelial cells (non-receptor mediated phototoxicity)	Oncology
padeliporfin VTP	padeliporfin VTP	phase 3	Photosensitizer		Oncology
TOOKAD® Soluble	TOOKAD® Soluble	phase 3	Photodynamic therapy agent	Vascular endothelial cells (non-receptor mediated phototoxicity)	Oncology

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Biofrontera Bioscience GmbH · 1 shared drug class
DUSA Pharmaceuticals, Inc. · 1 shared drug class
Galderma R&D · 1 shared drug class
Joint Authority for Päijät-Häme Social and Health Care · 1 shared drug class
National Cancer Center, Korea · 1 shared drug class
Photocure · 1 shared drug class
Psoriasis Treatment Center of Central New Jersey · 1 shared drug class
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Steba Biotech S.A.:

Cite this brief

Drug Landscape (2026). Steba Biotech S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/steba-biotech-s-a. Accessed 2026-06-10.